Lower limb complications are a substantial matter in the diabetic population and studies show
that the annual incidence of foot ulcers ranges from 1.0-4.1% while the cumulative lifetime
incidence is approximately 15%. Foot ulcers may become complicated by infection or gangrene,
and ultimately result in amputation. In addition, foot ulcers have a significant impact on
quality of life (QoL). The treatment of diabetic foot ulcers has not made substantial
progress in recent years with regards to improved healing although there have been several
actions taken to update the process. The current practice consists of wound debridement,
treatment of underlying infections and pressure relief. This trial investigates the
adjunctive effects of high (80 mg) or low (10 mg) dose atorvastatin to conventional treatment
on the healing of diabetic foot ulcers.